Activated p38 MAPK in peripheral blood monocytes of steroid resistant asthmatics

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Li, Ling Bo ^a   Leung, Donald Y M ^a,b   Goleva, Elena ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CD14 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LONG ACTING DRUG; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN AND STRESS ACTIVATED PROTEIN KINASE 1; PREDNISONE; PROTEIN SERINE THREONINE KINASE; SALBUTAMOL; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; MITOGEN AND STRESS-ACTIVATED PROTEIN KINASE 1; S6 KINASE;

ADULT; ARTICLE; ASTHMA; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; MALE; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; THERAPY RESISTANCE; BLOOD; DRUG RESISTANCE; GENETICS; METABOLISM;

ADULT; ASTHMA; DRUG RESISTANCE; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PREDNISONE; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA;

EID: 84950259849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141909     Document Type: Article

References (36)

1. Ramamoorthy S, Cidlowski JA. Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance. Endocr Dev. 2013; 24:41-56. doi: 10.1159/000342502 PMID: 23392094.
2. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2013; 131(3):636-45. doi: 10.1016/j.jaci.2012.12.1564 PMID: 23360759.
3. McManus R. Mechanisms of steroid action and resistance in inflammation and disease. J Endocrinol. 2003; 178(1):1-4. Epub 2003/07/08. PMID: 12844329.
4. Leung DY, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003; 111(1):3-22; quiz 3. Epub 2003/01/18. doi: S009167490291359X [pii]. PMID: 12532089.
5. Althuis MD, Sexton M, Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J Asthma. 1999; 36(3):257-64. Epub 1999/06/01. PMID: 10350222.
6. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010; 181(7):699-704. Epub 2010/01/16. doi: 200911-1710OC [pii] doi: 10.1164/rccm.200911-1710OC PMID: 20075384; PubMed Central PMCID: PMC2868500.
7. Yang M, Kumar RK, Foster PS. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-gamma and TLR4/MyD88 pathways. J Immunol. 2009; 182(8):5107-15. Epub 2009/ 04/04. doi: 182/8/5107 [pii] doi: 10.4049/jimmunol.0803468 PMID: 19342691.
8. Goleva E, Hauk PJ, Hall CF, Liu AH, Riches DW, Martin RJ, et al. Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J Allergy Clin Immunol. 2008; 122(3):550-9 e3. Epub 2008/09/09. doi: S0091-6749(08)01313-4 [pii] doi: 10.1016/j.jaci.2008.07.007 PMID: 18774390.
9. Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, et al. Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax. 2008; 63 (9):784-90. Epub 2008/05/22. doi: thx.2007.090027 [pii] doi: 10.1136/thx.2007.090027 PMID: 18492738.
10. Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall CF, et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med. 2013; 188 (10):1193-201. doi: 10.1164/rccm.201304-0775OC PMID: 24024497; PubMed Central PMCID: PMC3863730.
11. Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol. 1999; 20(4):751-8. Epub 1999/04/01. PMID: 10101008.
12. Lim W, Gee K, Mishra S, Kumar A. Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells. J Immunol. 2005; 175(9):5690-700. Epub 2005/10/21. doi: 175/9/5690 [pii] PMID: 16237059.
13. Rawadi G, Garcia J, Lemercier B, Roman-Roman S. Signal transduction pathways involved in the activation of NF-kappa B, AP-1, and c-fos by Mycoplasma fermentans membrane lipoproteins in macrophages. J Immunol. 1999; 162(4):2193-203. Epub 1999/02/11. PMID: 9973495.
14. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol. 2011; 12(8):695-708. Epub 2011/07/21. doi: ni.2065 [pii] doi: 10.1038/ni.2065 PMID: 21772278.
15. Liu Y, Shepherd EG, Nelin LD. MAPK phosphatases-regulating the immune response. Nat Rev Immunol. 2007; 7(3):202-12. Epub 2007/02/24. doi: nri2035 [pii] doi: 10.1038/nri2035 PMID: 17318231.
16. Lasa M, Abraham SM, Boucheron C, Saklatvala J, Clark AR. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol. 2002; 22(22):7802-11. Epub 2002/10/23. PMID: 12391149; PubMed Central PMCID: PMC134716.
17. Ismaili N, Garabedian MJ. Modulation of glucocorticoid receptor function via phosphorylation. Ann N Y Acad Sci. 2004; 1024:86-101. Epub 2004/07/22. doi: 10.1196/annals.1321.007 1024/1/86 [pii]. PMID: 15265775.
18. Galliher-Beckley AJ, Cidlowski JA. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease. IUBMB Life. 2009; 61(10):979-86. Epub 2009/09/30. doi: 10.1002/iub.245 PMID: 19787703.
19. Bhavsar P, Khorasani N, Hew M, Johnson M, Chung KF. Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma. Eur Respir J. 2010; 35(4):750-6. Epub 2009/ 10/21. doi: 09031936.00071309 [pii] doi: 10.1183/09031936.00071309 PMID: 19840967.
20. Chung KF. p38 mitogen-activated protein kinase pathways in asthma and COPD. Chest. 2011; 139 (6):1470-9. Epub 2011/06/10. doi: 139/6/1470 [pii] doi: 10.1378/chest.10-1914 PMID: 21652557.
21. Kumar S, Jiang MS, Adams JL, Lee JC. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun. 1999; 263(3):825-31. Epub 1999/10/08. doi: 10.1006/bbrc.1999.1454 S0006-291X(99)91454-7 [pii]. PMID: 10512765.
22. Liu W, Tundwal K, Liang Q, Goplen N, Rozario S, Quayum N, et al. Establishment of extracellular signal- regulated kinase 1/2 bistability and sustained activation through Sprouty 2 and its relevance for epithelial function. Mol Cell Biol. 2010; 30(7):1783-99. Epub 2010/02/04. doi: MCB.01003-09 [pii] doi:10. 1128/MCB.01003-09 PMID: 20123980; PubMed Central PMCID: PMC2838067.
23. Shan L, Redhu NS, Saleh A, Halayko AJ, Chakir J, Gounni AS. Thymic stromal lymphopoietin receptormediated IL-6 and CC/CXC chemokines expression in human airway smooth muscle cells: role of MAPKs (ERK1/2, p38, and JNK) and STAT3 pathways. J Immunol. 2010; 184(12):7134-43. Epub 2010/05/21. doi: jimmunol.0902515 [pii] doi: 10.4049/jimmunol.0902515 PMID: 20483734.
24. Liu W, Liang Q, Balzar S, Wenzel S, Gorska M, Alam R. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. J Allergy Clin Immunol. 2008; 121(4):893-902 e2. Epub 2008/04/09. doi: S0091-6749 (08)00350-3 [pii] doi: 10.1016/j.jaci.2008.02.004 PMID: 18395552.
25. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 1997; 7(9):353-61. doi: 10.1016/S0962-8924(97)01105-7 PMID: 17708980.
26. Enslen H, Brancho DM, Davis RJ. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 2000; 19(6):1301-11. doi: 10.1093/emboj/19.6.1301 PMID: 10716930; PubMed Central PMCID: PMCPMC305671.
27. Lee JC, Kassis S, Kumar S, Badger A, Adams JL. p38 mitogen-activated protein kinase inhibitors- mechanisms and therapeutic potentials. Pharmacol Ther. 1999; 82(2-3):389-97. PMID: 10454214.
28. Mercado N, To Y, Kobayashi Y, Adcock IM, Barnes PJ, Ito K. p38 mitogen-activated protein kinasegamma inhibition by long-acting beta2 adrenergic agonists reversed steroid insensitivity in severe asthma. Mol Pharmacol. 2011; 80(6):1128-35. doi: 10.1124/mol.111.071993 PMID: 21917909; PubMed Central PMCID: PMCPMC3228526.
29. Gallelli L, Pelaia G, Fratto D, Muto V, Falcone D, Vatrella A, et al. Effects of budesonide on P38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells. Int J Immunopathol Pharmacol. 2010; 23(2):471-9. PMID: 20646342.
30. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 2003; 22(6):1313-24. Epub 2003/03/12. doi: 10.1093/emboj/cdg139 PMID: 12628924; PubMed Central PMCID: PMC151081.
31. Beck IM, Vanden Berghe W, Gerlo S, Bougarne N, Vermeulen L, De Bosscher K, et al. Glucocorticoids and mitogen- and stress-activated protein kinase 1 inhibitors: possible partners in the combat against inflammation. Biochem Pharmacol. 2009; 77(7):1194-205. Epub 2009/01/20. doi: S0006-2952(08) 00898-8 [pii] doi: 10.1016/j.bcp.2008.12.008 PMID: 19150610.
32. Beck IM, Vanden Berghe W, Vermeulen L, Bougarne N, Vander Cruyssen B, Haegeman G, et al. Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J. 2008; 27(12):1682-93. Epub 2008/05/31. doi: emboj200895 [pii] doi: 10.1038/emboj.2008.95 PMID: 18511904; PubMed Central PMCID: PMC2435130.
33. Mercado N, Hakim A, Kobayashi Y, Meah S, Usmani OS, Chung KF, et al. Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma. PloS one. 2012; 7(7):e41582. doi: 10.1371/journal.pone.0041582 PMID: 22911818; PubMed Central PMCID: PMC3402424.
34. Lea S, Harbron C, Khan N, Booth G, Armstrong J, Singh D. Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitor. British journal of clinical pharmacology. 2015; 79(5):756-66. doi: 10.1111/bcp.12536 PMID: 25358442; PubMed Central PMCID: PMC4415712.
35. Khorasani N, Baker J, Johnson M, Chung KF, Bhavsar PK. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD. International journal of chronic obstructive pulmonary disease. 2015; 10:283-91. doi: 10.2147/COPD.S72403 PMID: 25678784; PubMed Central PMCID: PMC4322842.
36. Singh D, Smyth L, Borrill Z, Sweeney L, Tal-Singer R. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. Journal of clinical pharmacology. 2010; 50(1):94-100. doi: 10.1177/0091270009347873 PMID: 19880675.